These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 94437)

  • 1. [Recurrent jaundice in the course of natural and iatrogenic estrogen metabolism disorders].
    Mach G; Gładysz A
    Pol Tyg Lek; 1979 Dec; 34(49):1923-4. PubMed ID: 94437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of an oral contraceptive Femigen-Polfa by epileptic women].
    Rościszewska D
    Neurol Neurochir Pol; 1973; 7(5):715-7. PubMed ID: 4128492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Menstruation disorders due to Ovosiston medication].
    Kühndel K; Ebeling K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
    [No Abstract]   [Full Text] [Related]  

  • 4. [Migraine and hormonal contraceptives].
    Grässler W; Olthoff KH
    Z Arztl Fortbild (Jena); 1984; 78(6):229-32. PubMed ID: 6203234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Are oral contraceptives contraindicated after pregnancy hepatosis?].
    Rannevik G; Jeppsson S; Kullander S; Laurell CB
    Nord Med; 1971 Aug; 86(33):986. PubMed ID: 4106201
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors in endometrial carcinoma with special reference to the use of estrogens.
    Salmi T
    Acta Obstet Gynecol Scand Suppl; 1979; 86():1-119. PubMed ID: 377899
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intrahepatic cholestasis in hormonal contraception--a case with a difficult and expensive differential diagnosis].
    Böhme HH; Otto HJ
    Zentralbl Gynakol; 1985; 107(5):311-2. PubMed ID: 2581395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Normal sequential treatment. experiences with an 11:10 variant of the sequential method for contraception and for medical indications].
    Schmidt H; Langner A; Kaiser R
    Munch Med Wochenschr; 1970 Oct; 112(42):1903-13. PubMed ID: 4097638
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
    Mikrut W
    Wiad Lek; 1983 Oct; 36(19):1587-92. PubMed ID: 6198806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of oral contraceptives and epsilon-aminocaproic acid on pregnant female rats and their fetuses. Histopathologic study].
    Niznikowska-Marks MJ; Oknińska A; Gawlik Z; Grygalewicz J; Galczak W; Ostojska J
    Patol Pol; 1981; 32(1):37-52. PubMed ID: 6171763
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amenorrhea-galactorrhea following the use of ovosiston].
    Kosowski I; Stojanow G; Iliewa W
    Zentralbl Gynakol; 1973 Jun; 95(25):851-4. PubMed ID: 4126137
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of selected estrogens and progestins on human chromosomes in vitro.
    Stenchever MA; Jarvis JA; Kreger NK
    Obstet Gynecol; 1969 Aug; 34(2):249-51. PubMed ID: 4183817
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytogenetic study of blood in women who had used oral contraceptives.
    Fridrichová I
    Neoplasma; 1990; 37(5):545-53. PubMed ID: 1700312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Jaundice in intrahepatic cholestasis after ovulation inhibitors].
    Piesbergen H
    Med Welt; 1968 Feb; 9():451-3. PubMed ID: 4181421
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pills and minipills].
    Koffel JC
    Bull Soc Pharm Strasb; 1978; 21(1):43-53. PubMed ID: 12261367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Menstruation and endometrium after hormonal contraception].
    Böhm W; Klinger G; Hempel E
    Zentralbl Gynakol; 1972 Jul; 94(30):945-51. PubMed ID: 4118151
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign cholestatic jaundice of pregnancy and benign cholestatic jaundice from oral contraceptives.
    Drill VA
    Am J Obstet Gynecol; 1974 May; 119(2):165-74. PubMed ID: 4595936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
    Vesper VB; Feustel S
    Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 20. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.